Taiyuan Jiaqiao Translation Service Co., Ltd. – Trademark Portfolio

Entity Type: 99

Taiyuan Jiaqiao Translation Service Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include LELOBARPAL. The owner is based in Shanxi Province.

Unit 5, Unit 3, No. 17 Xigong East St.,

Wanbailin District, Taiyuan City,

Shanxi Province 030000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Taiyuan Jiaqiao Translation Service Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Taiyuan Jiaqiao Translation Service Co., Ltd. have?

Taiyuan Jiaqiao Translation Service Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Taiyuan Jiaqiao Translation Service Co., Ltd. file in?

Taiyuan Jiaqiao Translation Service Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Taiyuan Jiaqiao Translation Service Co., Ltd.'s most well-known trademarks?

Taiyuan Jiaqiao Translation Service Co., Ltd.'s registered trademark portfolio includes well-known marks such as LELOBARPAL. These are among 1 currently registered trademark in the portfolio.

What is Taiyuan Jiaqiao Translation Service Co., Ltd.'s trademark registration success rate?

Taiyuan Jiaqiao Translation Service Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.